These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy. Walsh Z, Thiessen MS. Int Rev Psychiatry; 2018 Aug; 30(4):343-349. PubMed ID: 30251904 [Abstract] [Full Text] [Related]
25. Mindfulness meditation and psychedelics: potential synergies and commonalities. Holas P, Kamińska J. Pharmacol Rep; 2023 Dec; 75(6):1398-1409. PubMed ID: 37926796 [Abstract] [Full Text] [Related]
28. Predicting Responses to Psychedelics: A Prospective Study. Haijen ECHM, Kaelen M, Roseman L, Timmermann C, Kettner H, Russ S, Nutt D, Daws RE, Hampshire ADG, Lorenz R, Carhart-Harris RL. Front Pharmacol; 2018 Dec; 9():897. PubMed ID: 30450045 [Abstract] [Full Text] [Related]
29. The acute effects of classic psychedelics on memory in humans. Healy CJ. Psychopharmacology (Berl); 2021 Mar; 238(3):639-653. PubMed ID: 33420592 [Abstract] [Full Text] [Related]
30. Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States. Davis AK, Agin-Liebes G, España M, Pilecki B, Luoma J. J Psychoactive Drugs; 2022 Mar; 54(4):309-318. PubMed ID: 34468293 [Abstract] [Full Text] [Related]
31. Understanding subjective experience in psychedelic-assisted psychotherapy: The need for phenomenology. Miceli McMillan R, Fernandez AV. Aust N Z J Psychiatry; 2023 Jun; 57(6):783-788. PubMed ID: 36384307 [Abstract] [Full Text] [Related]
32. [The nursing role in psychedelic-assisted psychotherapy]. Amberger C, Szczesniak L. Rev Infirm; 2024 Jun; 73(303):45-48. PubMed ID: 39209402 [Abstract] [Full Text] [Related]
33. Psychedelics, placebo effects, and set and setting: Insights from common factors theory of psychotherapy. Gukasyan N, Nayak SM. Transcult Psychiatry; 2022 Oct; 59(5):652-664. PubMed ID: 33499762 [Abstract] [Full Text] [Related]
34. Acute Subjective Effects of Psychedelics within and Beyond WEIRD Contexts. Graziosi M, Singh M, Nayak SM, Yaden DB. J Psychoactive Drugs; 2023 Oct; 55(5):558-569. PubMed ID: 37679890 [Abstract] [Full Text] [Related]
35. Psychosis and psychedelics: Historical entanglements and contemporary contrasts. Friesen P. Transcult Psychiatry; 2022 Oct; 59(5):592-609. PubMed ID: 36300247 [Abstract] [Full Text] [Related]
36. Perspectives and preliminary experiences of psychedelics for the treatment of eating disorders: A systematic scoping review. Cuerva K, Spirou D, Cuerva A, Delaquis C, Raman J. Eur Eat Disord Rev; 2024 Sep; 32(5):980-1001. PubMed ID: 38783636 [Abstract] [Full Text] [Related]
37. Psychedelics and neonihilism: connectedness in a meaningless world. Plesa P, Petranker R. Front Psychol; 2023 Sep; 14():1125780. PubMed ID: 37621941 [Abstract] [Full Text] [Related]
38. Do Psychedelics Facilitate Emergence of Unconscious Psychological Processes? Lindegaard T. Psychodyn Psychiatry; 2023 Sep; 51(3):270-286. PubMed ID: 37712665 [Abstract] [Full Text] [Related]
39. Characteristics of change in Ericksonian hypnotherapy: a cognitive-psychological perspective. Otani A. Am J Clin Hypn; 1990 Jul; 33(1):29-39. PubMed ID: 2220654 [Abstract] [Full Text] [Related]
40. Modalities of the psychedelic experience: Microclimates of set and setting in hallucinogen research and culture. Hartogsohn I. Transcult Psychiatry; 2022 Oct; 59(5):579-591. PubMed ID: 35818775 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]